In an insured population with advanced lung cancer, clinical trial participants had lower or similar total health care costs compared with nonparticipants.
|Articles|December 1, 2002
Supplements and Featured Publications
- Health-Related Consequences of and Treatment Strategies for Overactive Bladder
- Volume 8
- Issue 19 Suppl
Long-term Health-Related Quality of Life of Patients Receiving Extended-Release Tolterodine for Overactive Bladder
Advertisement
Articles in this issue
almost 24 years ago
Participating Facultyalmost 24 years ago
Health-Related Consequences of Overactive BladderAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
3
Cranberry Supplement Tied to Greater OAB Score Reductions in Pilot Trial
4
Disease Extent Linked to Complications After Deep Endometriosis Surgery
5